nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—Alkylating Activity—Melphalan—peripheral nervous system neoplasm	0.377	0.556	CiPCiCtD
Estramustine—Alkylating Activity—Dacarbazine—peripheral nervous system neoplasm	0.302	0.444	CiPCiCtD
Estramustine—ABCB1—peripheral nervous system neoplasm	0.144	1	CbGaD
Estramustine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0163	0.167	CbGbCtD
Estramustine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0163	0.167	CbGbCtD
Estramustine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0113	0.116	CbGbCtD
Estramustine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00974	0.1	CbGbCtD
Estramustine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00906	0.0931	CbGbCtD
Estramustine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00694	0.0714	CbGbCtD
Estramustine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00647	0.0666	CbGbCtD
Estramustine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00636	0.0654	CbGbCtD
Estramustine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00434	0.0446	CbGbCtD
Estramustine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00416	0.0428	CbGbCtD
Estramustine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00381	0.0392	CbGbCtD
Estramustine—MAP1A—ganglion—peripheral nervous system neoplasm	0.00267	0.214	CbGeAlD
Estramustine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0026	0.0267	CbGbCtD
Estramustine—MAP2—nerve—peripheral nervous system neoplasm	0.00154	0.123	CbGeAlD
Estramustine—MAP2—ganglion—peripheral nervous system neoplasm	0.00152	0.122	CbGeAlD
Estramustine—MAP1A—trigeminal ganglion—peripheral nervous system neoplasm	0.00131	0.105	CbGeAlD
Estramustine—ESR2—Validated nuclear estrogen receptor beta network—SMARCB1—peripheral nervous system neoplasm	0.00119	0.13	CbGpPWpGaD
Estramustine—MAP1A—brainstem—peripheral nervous system neoplasm	0.00116	0.0931	CbGeAlD
Estramustine—MAP2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000906	0.0989	CbGpPWpGaD
Estramustine—MAP2—trigeminal ganglion—peripheral nervous system neoplasm	0.000746	0.0598	CbGeAlD
Estramustine—MAP2—parotid gland—peripheral nervous system neoplasm	0.000704	0.0564	CbGeAlD
Estramustine—MAP2—brainstem—peripheral nervous system neoplasm	0.000661	0.0529	CbGeAlD
Estramustine—MAP1A—cerebellum—peripheral nervous system neoplasm	0.000573	0.0459	CbGeAlD
Estramustine—ESR2—brainstem—peripheral nervous system neoplasm	0.000428	0.0343	CbGeAlD
Estramustine—ESR2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000349	0.0381	CbGpPWpGaD
Estramustine—MAP2—cerebellum—peripheral nervous system neoplasm	0.000326	0.0261	CbGeAlD
Estramustine—MAP2—MAPK Cascade—NRAS—peripheral nervous system neoplasm	0.000313	0.0342	CbGpPWpGaD
Estramustine—ESR1—brainstem—peripheral nervous system neoplasm	0.000293	0.0235	CbGeAlD
Estramustine—MAP2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000261	0.0285	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000239	0.0261	CbGpPWpGaD
Estramustine—MAP2—MAPK Cascade—HRAS—peripheral nervous system neoplasm	0.000229	0.025	CbGpPWpGaD
Estramustine—Cardiac failure congestive—Cisplatin—peripheral nervous system neoplasm	0.000217	0.00375	CcSEcCtD
Estramustine—Embolism—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00375	CcSEcCtD
Estramustine—MAP2—LKB1 signaling events—MYC—peripheral nervous system neoplasm	0.000213	0.0232	CbGpPWpGaD
Estramustine—Dry skin—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.00366	CcSEcCtD
Estramustine—Cardiac arrest—Vincristine—peripheral nervous system neoplasm	0.000212	0.00366	CcSEcCtD
Estramustine—ESR2—cerebellum—peripheral nervous system neoplasm	0.000211	0.0169	CbGeAlD
Estramustine—Pancytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000205	0.00353	CcSEcCtD
Estramustine—Cerebrovascular accident—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00347	CcSEcCtD
Estramustine—Embolism—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.00347	CcSEcCtD
Estramustine—Hypercalcaemia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.00346	CcSEcCtD
Estramustine—Cardiac failure congestive—Etoposide—peripheral nervous system neoplasm	0.000199	0.00344	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Cisplatin—peripheral nervous system neoplasm	0.000197	0.0034	CcSEcCtD
Estramustine—Tinnitus—Tretinoin—peripheral nervous system neoplasm	0.000197	0.0034	CcSEcCtD
Estramustine—Tinnitus—Isotretinoin—peripheral nervous system neoplasm	0.000197	0.0034	CcSEcCtD
Estramustine—Flushing—Tretinoin—peripheral nervous system neoplasm	0.000196	0.00338	CcSEcCtD
Estramustine—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.000196	0.00338	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000195	0.0213	CbGpPWpGaD
Estramustine—Flushing—Melphalan—peripheral nervous system neoplasm	0.000193	0.00334	CcSEcCtD
Estramustine—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.00331	CcSEcCtD
Estramustine—Estriol—ABCB1—peripheral nervous system neoplasm	0.000191	0.317	CrCbGaD
Estramustine—Alopecia—Topotecan—peripheral nervous system neoplasm	0.000188	0.00325	CcSEcCtD
Estramustine—Alopecia—Tretinoin—peripheral nervous system neoplasm	0.000187	0.00322	CcSEcCtD
Estramustine—Alopecia—Isotretinoin—peripheral nervous system neoplasm	0.000187	0.00322	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000186	0.0203	CbGpPWpGaD
Estramustine—Hypercalcaemia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.0032	CcSEcCtD
Estramustine—Alopecia—Melphalan—peripheral nervous system neoplasm	0.000184	0.00318	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.000183	0.02	CbGpPWpGaD
Estramustine—Pancytopenia—Vincristine—peripheral nervous system neoplasm	0.000183	0.00316	CcSEcCtD
Estramustine—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.000181	0.00313	CcSEcCtD
Estramustine—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.000181	0.00313	CcSEcCtD
Estramustine—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.000178	0.00307	CcSEcCtD
Estramustine—Depression—Alitretinoin—peripheral nervous system neoplasm	0.000178	0.00307	CcSEcCtD
Estramustine—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.000177	0.00306	CcSEcCtD
Estramustine—Acute coronary syndrome—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.00303	CcSEcCtD
Estramustine—ESR1—Estrogen signaling pathway—GNAS—peripheral nervous system neoplasm	0.000175	0.0192	CbGpPWpGaD
Estramustine—Myocardial infarction—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.00302	CcSEcCtD
Estramustine—MAP2—LKB1 signaling events—TP53—peripheral nervous system neoplasm	0.000175	0.0191	CbGpPWpGaD
Estramustine—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.000172	0.00296	CcSEcCtD
Estramustine—Depression—Vincristine—peripheral nervous system neoplasm	0.000171	0.00296	CcSEcCtD
Estramustine—Dysphonia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.00292	CcSEcCtD
Estramustine—Acute coronary syndrome—Vincristine—peripheral nervous system neoplasm	0.000169	0.00292	CcSEcCtD
Estramustine—Myocardial infarction—Vincristine—peripheral nervous system neoplasm	0.000168	0.00291	CcSEcCtD
Estramustine—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.000166	0.00286	CcSEcCtD
Estramustine—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000163	0.00282	CcSEcCtD
Estramustine—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.000162	0.0028	CcSEcCtD
Estramustine—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.000162	0.00279	CcSEcCtD
Estramustine—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.00016	0.00276	CcSEcCtD
Estramustine—Chest pain—Topotecan—peripheral nervous system neoplasm	0.000158	0.00272	CcSEcCtD
Estramustine—Dysphonia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.00271	CcSEcCtD
Estramustine—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.000157	0.0027	CcSEcCtD
Estramustine—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.000157	0.0027	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000156	0.017	CbGpPWpGaD
Estramustine—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.000156	0.00269	CcSEcCtD
Estramustine—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.000156	0.00269	CcSEcCtD
Estramustine—Chest pain—Melphalan—peripheral nervous system neoplasm	0.000154	0.00267	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.000153	0.0167	CbGpPWpGaD
Estramustine—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.000153	0.00263	CcSEcCtD
Estramustine—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00261	CcSEcCtD
Estramustine—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00015	0.00259	CcSEcCtD
Estramustine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00015	0.00259	CcSEcCtD
Estramustine—Acute coronary syndrome—Cisplatin—peripheral nervous system neoplasm	0.00015	0.00258	CcSEcCtD
Estramustine—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.00257	CcSEcCtD
Estramustine—Myocardial infarction—Cisplatin—peripheral nervous system neoplasm	0.000149	0.00257	CcSEcCtD
Estramustine—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.00256	CcSEcCtD
Estramustine—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.000148	0.00256	CcSEcCtD
Estramustine—Oedema—Melphalan—peripheral nervous system neoplasm	0.000148	0.00256	CcSEcCtD
Estramustine—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000148	0.00256	CcSEcCtD
Estramustine—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000147	0.00253	CcSEcCtD
Estramustine—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000147	0.00253	CcSEcCtD
Estramustine—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000145	0.0025	CcSEcCtD
Estramustine—ESR1—cerebellum—peripheral nervous system neoplasm	0.000145	0.0116	CbGeAlD
Estramustine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000144	0.00249	CcSEcCtD
Estramustine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000143	0.00247	CcSEcCtD
Estramustine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000143	0.00247	CcSEcCtD
Estramustine—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.00244	CcSEcCtD
Estramustine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000141	0.00244	CcSEcCtD
Estramustine—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00242	CcSEcCtD
Estramustine—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.000137	0.00237	CcSEcCtD
Estramustine—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.000137	0.00237	CcSEcCtD
Estramustine—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.000136	0.00235	CcSEcCtD
Estramustine—Alopecia—Vincristine—peripheral nervous system neoplasm	0.000136	0.00235	CcSEcCtD
Estramustine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000136	0.00234	CcSEcCtD
Estramustine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000136	0.00234	CcSEcCtD
Estramustine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000135	0.00233	CcSEcCtD
Estramustine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000135	0.00232	CcSEcCtD
Estramustine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000134	0.00231	CcSEcCtD
Estramustine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000134	0.00231	CcSEcCtD
Estramustine—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.000133	0.0023	CcSEcCtD
Estramustine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000132	0.00228	CcSEcCtD
Estramustine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000131	0.00227	CcSEcCtD
Estramustine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000131	0.0105	CbGeAlD
Estramustine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000131	0.0143	CbGpPWpGaD
Estramustine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00013	0.00225	CcSEcCtD
Estramustine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00013	0.00225	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—CHEK2—peripheral nervous system neoplasm	0.000129	0.0141	CbGpPWpGaD
Estramustine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000129	0.00222	CcSEcCtD
Estramustine—Cramps of lower extremities—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00221	CcSEcCtD
Estramustine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000127	0.00219	CcSEcCtD
Estramustine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000127	0.00218	CcSEcCtD
Estramustine—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00213	CcSEcCtD
Estramustine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000123	0.00212	CcSEcCtD
Estramustine—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000121	0.00208	CcSEcCtD
Estramustine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00012	0.00207	CcSEcCtD
Estramustine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00012	0.00207	CcSEcCtD
Estramustine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000119	0.00205	CcSEcCtD
Estramustine—Cramps of lower extremities—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00205	CcSEcCtD
Estramustine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.00204	CcSEcCtD
Estramustine—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000117	0.00202	CcSEcCtD
Estramustine—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00202	CcSEcCtD
Estramustine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000117	0.00202	CcSEcCtD
Estramustine—ESR1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.000116	0.0127	CbGpPWpGaD
Estramustine—Flushing—Etoposide—peripheral nervous system neoplasm	0.000116	0.002	CcSEcCtD
Estramustine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000114	0.00197	CcSEcCtD
Estramustine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.00196	CcSEcCtD
Estramustine—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00193	CcSEcCtD
Estramustine—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00193	CcSEcCtD
Estramustine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.00192	CcSEcCtD
Estramustine—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000111	0.0121	CbGpPWpGaD
Estramustine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00011	0.0019	CcSEcCtD
Estramustine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00011	0.00189	CcSEcCtD
Estramustine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.00187	CcSEcCtD
Estramustine—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.000108	0.00187	CcSEcCtD
Estramustine—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.00187	CcSEcCtD
Estramustine—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00185	CcSEcCtD
Estramustine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000107	0.00185	CcSEcCtD
Estramustine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000107	0.00185	CcSEcCtD
Estramustine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.00184	CcSEcCtD
Estramustine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000106	0.00183	CcSEcCtD
Estramustine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000106	0.00183	CcSEcCtD
Estramustine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000106	0.00183	CcSEcCtD
Estramustine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000105	0.00181	CcSEcCtD
Estramustine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000105	0.0018	CcSEcCtD
Estramustine—Ethinyl Estradiol—ABCB1—peripheral nervous system neoplasm	0.000104	0.173	CrCbGaD
Estramustine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000104	0.0018	CcSEcCtD
Estramustine—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00179	CcSEcCtD
Estramustine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000103	0.00179	CcSEcCtD
Estramustine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00178	CcSEcCtD
Estramustine—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00178	CcSEcCtD
Estramustine—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.00178	CcSEcCtD
Estramustine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.00177	CcSEcCtD
Estramustine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000103	0.00177	CcSEcCtD
Estramustine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000103	0.00177	CcSEcCtD
Estramustine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.00175	CcSEcCtD
Estramustine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000101	0.00175	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00175	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.000101	0.011	CbGpPWpGaD
Estramustine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000101	0.00174	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000101	0.011	CbGpPWpGaD
Estramustine—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.00173	CcSEcCtD
Estramustine—Affect lability—Epirubicin—peripheral nervous system neoplasm	9.96e-05	0.00172	CcSEcCtD
Estramustine—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.00171	CcSEcCtD
Estramustine—Insomnia—Vincristine—peripheral nervous system neoplasm	9.91e-05	0.00171	CcSEcCtD
Estramustine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	9.88e-05	0.00171	CcSEcCtD
Estramustine—Leukopenia—Etoposide—peripheral nervous system neoplasm	9.74e-05	0.00168	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	9.72e-05	0.0106	CbGpPWpGaD
Estramustine—Oedema—Cisplatin—peripheral nervous system neoplasm	9.69e-05	0.00167	CcSEcCtD
Estramustine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	9.63e-05	0.00166	CcSEcCtD
Estramustine—Vomiting—Topotecan—peripheral nervous system neoplasm	9.62e-05	0.00166	CcSEcCtD
Estramustine—Mood swings—Epirubicin—peripheral nervous system neoplasm	9.59e-05	0.00165	CcSEcCtD
Estramustine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.00165	CcSEcCtD
Estramustine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.00165	CcSEcCtD
Estramustine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	9.54e-05	0.00165	CcSEcCtD
Estramustine—Vomiting—Tretinoin—peripheral nervous system neoplasm	9.54e-05	0.00165	CcSEcCtD
Estramustine—Rash—Topotecan—peripheral nervous system neoplasm	9.54e-05	0.00165	CcSEcCtD
Estramustine—Dermatitis—Topotecan—peripheral nervous system neoplasm	9.53e-05	0.00164	CcSEcCtD
Estramustine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	9.53e-05	0.00164	CcSEcCtD
Estramustine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	9.49e-05	0.00164	CcSEcCtD
Estramustine—Headache—Topotecan—peripheral nervous system neoplasm	9.48e-05	0.00163	CcSEcCtD
Estramustine—Rash—Isotretinoin—peripheral nervous system neoplasm	9.46e-05	0.00163	CcSEcCtD
Estramustine—Rash—Tretinoin—peripheral nervous system neoplasm	9.46e-05	0.00163	CcSEcCtD
Estramustine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	9.45e-05	0.00163	CcSEcCtD
Estramustine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	9.45e-05	0.00163	CcSEcCtD
Estramustine—Vomiting—Melphalan—peripheral nervous system neoplasm	9.42e-05	0.00162	CcSEcCtD
Estramustine—Headache—Tretinoin—peripheral nervous system neoplasm	9.4e-05	0.00162	CcSEcCtD
Estramustine—Headache—Isotretinoin—peripheral nervous system neoplasm	9.4e-05	0.00162	CcSEcCtD
Estramustine—ESR1—FOXM1 transcription factor network—BIRC5—peripheral nervous system neoplasm	9.39e-05	0.0103	CbGpPWpGaD
Estramustine—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	9.37e-05	0.00162	CcSEcCtD
Estramustine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.00161	CcSEcCtD
Estramustine—Rash—Melphalan—peripheral nervous system neoplasm	9.34e-05	0.00161	CcSEcCtD
Estramustine—Dermatitis—Melphalan—peripheral nervous system neoplasm	9.33e-05	0.00161	CcSEcCtD
Estramustine—Dry skin—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.0016	CcSEcCtD
Estramustine—Chest pain—Etoposide—peripheral nervous system neoplasm	9.26e-05	0.0016	CcSEcCtD
Estramustine—Anorexia—Cisplatin—peripheral nervous system neoplasm	9.24e-05	0.00159	CcSEcCtD
Estramustine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	9.22e-05	0.00159	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	9.21e-05	0.0101	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	9.15e-05	0.00999	CbGpPWpGaD
Estramustine—Conjugated Estrogens—ABCB1—peripheral nervous system neoplasm	9.13e-05	0.152	CrCbGaD
Estramustine—Estrone—ABCB1—peripheral nervous system neoplasm	9.1e-05	0.151	CrCbGaD
Estramustine—Nausea—Topotecan—peripheral nervous system neoplasm	8.98e-05	0.00155	CcSEcCtD
Estramustine—Nausea—Tretinoin—peripheral nervous system neoplasm	8.91e-05	0.00154	CcSEcCtD
Estramustine—Nausea—Isotretinoin—peripheral nervous system neoplasm	8.91e-05	0.00154	CcSEcCtD
Estramustine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	8.91e-05	0.00154	CcSEcCtD
Estramustine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.00153	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	8.82e-05	0.00963	CbGpPWpGaD
Estramustine—Nausea—Melphalan—peripheral nervous system neoplasm	8.8e-05	0.00152	CcSEcCtD
Estramustine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	8.69e-05	0.0015	CcSEcCtD
Estramustine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.00149	CcSEcCtD
Estramustine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	8.64e-05	0.00149	CcSEcCtD
Estramustine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.00148	CcSEcCtD
Estramustine—Anorexia—Etoposide—peripheral nervous system neoplasm	8.46e-05	0.00146	CcSEcCtD
Estramustine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	8.42e-05	0.00145	CcSEcCtD
Estramustine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	8.39e-05	0.00145	CcSEcCtD
Estramustine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	8.31e-05	0.00143	CcSEcCtD
Estramustine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	8.05e-05	0.00139	CcSEcCtD
Estramustine—ESR1—Nuclear signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	7.99e-05	0.00872	CbGpPWpGaD
Estramustine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	7.91e-05	0.00137	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	7.9e-05	0.00863	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	7.87e-05	0.00859	CbGpPWpGaD
Estramustine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.8e-05	0.00135	CcSEcCtD
Estramustine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.78e-05	0.00134	CcSEcCtD
Estramustine—Rash—Dactinomycin—peripheral nervous system neoplasm	7.73e-05	0.00133	CcSEcCtD
Estramustine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.72e-05	0.00133	CcSEcCtD
Estramustine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.00133	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	7.64e-05	0.00835	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	7.5e-05	0.00819	CbGpPWpGaD
Estramustine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.5e-05	0.00129	CcSEcCtD
Estramustine—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.28e-05	0.00126	CcSEcCtD
Estramustine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.23e-05	0.00125	CcSEcCtD
Estramustine—ESR1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	7.2e-05	0.00786	CbGpPWpGaD
Estramustine—Rash—Alitretinoin—peripheral nervous system neoplasm	7.17e-05	0.00124	CcSEcCtD
Estramustine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.16e-05	0.00124	CcSEcCtD
Estramustine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	7.14e-05	0.0078	CbGpPWpGaD
Estramustine—Headache—Alitretinoin—peripheral nervous system neoplasm	7.12e-05	0.00123	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	6.97e-05	0.00761	CbGpPWpGaD
Estramustine—Vomiting—Vincristine—peripheral nervous system neoplasm	6.97e-05	0.0012	CcSEcCtD
Estramustine—Rash—Vincristine—peripheral nervous system neoplasm	6.91e-05	0.00119	CcSEcCtD
Estramustine—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.9e-05	0.00119	CcSEcCtD
Estramustine—Estradiol—ABCB1—peripheral nervous system neoplasm	6.9e-05	0.115	CrCbGaD
Estramustine—Headache—Vincristine—peripheral nervous system neoplasm	6.86e-05	0.00118	CcSEcCtD
Estramustine—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.75e-05	0.00117	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	6.69e-05	0.00731	CbGpPWpGaD
Estramustine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.63e-05	0.00114	CcSEcCtD
Estramustine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	6.53e-05	0.00113	CcSEcCtD
Estramustine—Nausea—Vincristine—peripheral nervous system neoplasm	6.51e-05	0.00112	CcSEcCtD
Estramustine—Flushing—Epirubicin—peripheral nervous system neoplasm	6.5e-05	0.00112	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	6.38e-05	0.00697	CbGpPWpGaD
Estramustine—Pruritus—Etoposide—peripheral nervous system neoplasm	6.28e-05	0.00108	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	6.27e-05	0.00685	CbGpPWpGaD
Estramustine—ESR1—FOXM1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	6.22e-05	0.00679	CbGpPWpGaD
Estramustine—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.19e-05	0.00107	CcSEcCtD
Estramustine—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.16e-05	0.00106	CcSEcCtD
Estramustine—Rash—Cisplatin—peripheral nervous system neoplasm	6.11e-05	0.00105	CcSEcCtD
Estramustine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.1e-05	0.00105	CcSEcCtD
Estramustine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.07e-05	0.00105	CcSEcCtD
Estramustine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.00104	CcSEcCtD
Estramustine—Flushing—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.00104	CcSEcCtD
Estramustine—Flatulence—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.00104	CcSEcCtD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	5.97e-05	0.00652	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	5.91e-05	0.00646	CbGpPWpGaD
Estramustine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	5.86e-05	0.00101	CcSEcCtD
Estramustine—Nausea—Cisplatin—peripheral nervous system neoplasm	5.75e-05	0.000993	CcSEcCtD
Estramustine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	0.000988	CcSEcCtD
Estramustine—ABCB1—cerebellum—peripheral nervous system neoplasm	5.71e-05	0.00457	CbGeAlD
Estramustine—Vomiting—Etoposide—peripheral nervous system neoplasm	5.64e-05	0.000974	CcSEcCtD
Estramustine—Rash—Etoposide—peripheral nervous system neoplasm	5.6e-05	0.000966	CcSEcCtD
Estramustine—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.59e-05	0.000965	CcSEcCtD
Estramustine—Headache—Etoposide—peripheral nervous system neoplasm	5.56e-05	0.000959	CcSEcCtD
Estramustine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.000959	CcSEcCtD
Estramustine—Testosterone—ABCB1—peripheral nervous system neoplasm	5.53e-05	0.0919	CrCbGaD
Estramustine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000942	CcSEcCtD
Estramustine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.42e-05	0.000936	CcSEcCtD
Estramustine—ESR2—Gene Expression—EED—peripheral nervous system neoplasm	5.38e-05	0.00588	CbGpPWpGaD
Estramustine—Nausea—Etoposide—peripheral nervous system neoplasm	5.27e-05	0.00091	CcSEcCtD
Estramustine—ESR1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	5.2e-05	0.00568	CbGpPWpGaD
Estramustine—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000896	CcSEcCtD
Estramustine—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.000892	CcSEcCtD
Estramustine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000871	CcSEcCtD
Estramustine—Oedema—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000859	CcSEcCtD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	4.96e-05	0.00542	CbGpPWpGaD
Estramustine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000841	CcSEcCtD
Estramustine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000829	CcSEcCtD
Estramustine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000826	CcSEcCtD
Estramustine—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000818	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	4.73e-05	0.00517	CbGpPWpGaD
Estramustine—ESR1—Estrogen signaling pathway—AKT1—peripheral nervous system neoplasm	4.73e-05	0.00517	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	4.65e-05	0.00508	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	4.61e-05	0.00504	CbGpPWpGaD
Estramustine—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000794	CcSEcCtD
Estramustine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000778	CcSEcCtD
Estramustine—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000776	CcSEcCtD
Estramustine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000765	CcSEcCtD
Estramustine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000757	CcSEcCtD
Estramustine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000746	CcSEcCtD
Estramustine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	4.31e-05	0.0047	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—SUZ12—peripheral nervous system neoplasm	4.3e-05	0.0047	CbGpPWpGaD
Estramustine—ESR1—FOXM1 transcription factor network—MYC—peripheral nervous system neoplasm	4.22e-05	0.0046	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	4.21e-05	0.0046	CbGpPWpGaD
Estramustine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000718	CcSEcCtD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	4.16e-05	0.00455	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—MYC—peripheral nervous system neoplasm	4.14e-05	0.00452	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	4.13e-05	0.00451	CbGpPWpGaD
Estramustine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000708	CcSEcCtD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	4.1e-05	0.00448	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	4.01e-05	0.00437	CbGpPWpGaD
Estramustine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000691	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	3.92e-05	0.00428	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.85e-05	0.00421	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	3.75e-05	0.00409	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	3.74e-05	0.00409	CbGpPWpGaD
Estramustine—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.52e-05	0.000607	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.51e-05	0.00384	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.51e-05	0.00384	CbGpPWpGaD
Estramustine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.4e-05	0.000587	CcSEcCtD
Estramustine—ESR1—LKB1 signaling events—TP53—peripheral nervous system neoplasm	3.4e-05	0.00371	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	3.38e-05	0.00369	CbGpPWpGaD
Estramustine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.000562	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.22e-05	0.00351	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.19e-05	0.00348	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	3.16e-05	0.00346	CbGpPWpGaD
Estramustine—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.16e-05	0.000546	CcSEcCtD
Estramustine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000544	CcSEcCtD
Estramustine—Rash—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000541	CcSEcCtD
Estramustine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.13e-05	0.000541	CcSEcCtD
Estramustine—Headache—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000538	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	3.08e-05	0.00336	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	3.01e-05	0.00329	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	2.98e-05	0.00326	CbGpPWpGaD
Estramustine—Nausea—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.00051	CcSEcCtD
Estramustine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000505	CcSEcCtD
Estramustine—Rash—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000501	CcSEcCtD
Estramustine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.0005	CcSEcCtD
Estramustine—Headache—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	0.000498	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	2.87e-05	0.00313	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	2.8e-05	0.00306	CbGpPWpGaD
Estramustine—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.73e-05	0.000472	CcSEcCtD
Estramustine—ESR1—Gene Expression—EED—peripheral nervous system neoplasm	2.71e-05	0.00296	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	2.69e-05	0.00294	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	2.49e-05	0.00272	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.49e-05	0.00272	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	2.3e-05	0.00251	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—SUZ12—peripheral nervous system neoplasm	2.17e-05	0.00237	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	2.13e-05	0.00232	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	2.08e-05	0.00227	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.04e-05	0.00223	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.04e-05	0.00223	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	1.99e-05	0.00217	CbGpPWpGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.97e-05	0.00215	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.94e-05	0.00212	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.86e-05	0.00203	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	1.84e-05	0.00201	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.77e-05	0.00193	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	1.73e-05	0.00189	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.73e-05	0.00189	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.72e-05	0.00188	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.7e-05	0.00186	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.65e-05	0.00181	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	1.62e-05	0.00177	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.61e-05	0.00176	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.59e-05	0.00174	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	1.51e-05	0.00165	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.28e-05	0.00139	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.25e-05	0.00137	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	1.24e-05	0.00136	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.24e-05	0.00135	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.22e-05	0.00134	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	1.18e-05	0.00129	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.12e-05	0.00122	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.08e-05	0.00118	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.05e-05	0.00115	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	1.04e-05	0.00114	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.03e-05	0.00113	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.02e-05	0.00111	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.67e-06	0.00106	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	9.37e-06	0.00102	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	8.92e-06	0.000975	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.7e-06	0.000951	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	8.5e-06	0.000929	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.42e-06	0.000919	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	8.07e-06	0.000882	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	7.74e-06	0.000845	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	7.45e-06	0.000814	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.88e-06	0.000751	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.77e-06	0.00074	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.7e-06	0.000732	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	6.64e-06	0.000725	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	6.23e-06	0.000681	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MYC—peripheral nervous system neoplasm	5.95e-06	0.00065	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.73e-06	0.000626	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.46e-06	0.000597	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.45e-06	0.000596	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.01e-06	0.000548	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	4.97e-06	0.000543	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	4.89e-06	0.000534	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	4.77e-06	0.000521	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.6e-06	0.000503	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	4.59e-06	0.000501	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	4.13e-06	0.000451	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—AKT1—peripheral nervous system neoplasm	4.13e-06	0.000451	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.94e-06	0.000431	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	3.89e-06	0.000424	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.48e-06	0.000381	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	3.17e-06	0.000346	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.01e-06	0.000329	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	3e-06	0.000328	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.75e-06	0.000301	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.55e-06	0.000278	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.5e-06	0.000273	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.43e-06	0.000265	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.39e-06	0.000261	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.09e-06	0.000229	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	2.08e-06	0.000227	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.95e-06	0.000213	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.95e-06	0.000213	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.92e-06	0.000209	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.6e-06	0.000175	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.53e-06	0.000167	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.35e-06	0.000148	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	8.56e-07	9.35e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	5.28e-07	5.76e-05	CbGpPWpGaD
